Join
Live feed
·
PRReleasevia Quantisnow
Pulmatrix Inc. logo

Eos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting Mitochondria

ByQuantisnow·Wall Street's wire, on your screen.
PULM· Pulmatrix Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PULM (Pulmatrix Inc.) and more on Quantisnow.